Morgan Stanley Boosts Dividend and Share Repurchase Program

Morgan Stanley (NYSE: MS) has announced an increase in its quarterly common stock dividend to $0.925 per share, up from the current $0.85 per share. This marks the third consecutive year of dividend increases, reflecting the firm's confidence in its business model. Additionally, the board of directors has reauthorized a multi-year common equity share repurchase program of up to $20 billion, effective from the third quarter of 2024.

The firm's regulatory capital framework has also been impacted, with the board of governors of the Federal Reserve System releasing its CCAR 2024 results. As a result, Morgan Stanley expects to be subject to a stress capital buffer (SCB) of 6.0% from October 1, 2024, to September 30, 2025, leading to an aggregate U.S. Basel III standardized approach common equity tier 1 (CET1) ratio of 13.5%. This is a decrease from the firm's U.S. Basel III standardized approach CET1 ratio of 15.0% as of March 31, 2024.

Ted Pick, the chief executive officer of Morgan Stanley, emphasized that these results demonstrate the firm's continued execution of a clear and consistent strategy to raise, manage, and allocate capital for clients. These actions underscore the durability of Morgan Stanley's business model and its commitment to returning value to shareholders.

Morgan Stanley, a leading global financial services firm with a presence in 42 countries, provides a wide range of investment banking, securities, wealth management, and investment management services. This latest announcement reflects the firm's ongoing efforts to optimize its capital structure and maximize shareholder value. The market has reacted to these announcements by moving the company's shares 1.5% to a price of $97.19. For the full picture, make sure to review Morgan Stanley's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.